Albireo Pharma Inc (NASDAQ:ALBO)

Albireo Pharma Inc (NASDAQ:ALBO)


Share Price
$ 30.80
Change
-1.1 (-3.45 %)
Market Cap
$370.40 m
Proactive Investors - Run By Investors For Investors

Albireo Pharma Inc

Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders.  We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Our parent company, Albireo Pharma, Inc., is...

EPIC: ALBO
Market: NASDAQ:ALBO
52-week High/Low: $37.67 / $19.43
Sector: Pharma & Biotech
Market Cap: $370.40 m
Website:
col 3
col 4
col 5
col 6

Albireo Pharma Inc Timeline

Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use